A number of late-phase clinical trials in prostate cancer have opened in recent months. Maybe one of your patients could

Nearly 80% of men with metastatic prostate cancer died from their malignancy, according to a retrospective cohort study involving 26,000-plus

In a randomized trial of prostate cancer screening methods, a blood-based diagnostic test and MRI with subsequent targeted plus systematic

NEW YORK (Reuters Health) – Biomarkers can be used to identify patients with prostate cancer refractory to first-line androgen deprivation

NEW YORK (Reuters Health) – Loss of MAP3K7 protein expression, seen in approximately 40% of prostate cancer patients, is a